Ferric Carboxymaltose-Mediated Methemoglobinemia.
Current drug safety(2023)
摘要
No case or research reporting an increase in methemoglobin levels following oral and/or intravenous treatment to patients with iron deficiency anemia has been found in the literature. Therefore, this is the first contribution to the existing literature.
更多查看译文
关键词
anemia,ferric carboxymaltose,intravenous iron,iron deficiency,methemoglobinemia,side effect
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要